Kenvue Inc. (KVUE, Financial) experienced a significant stock drop of 5%, trading at $22.31 per share with a volume of 10.62 million shares and a turnover rate of 0.55%. The company's recent financial report shows revenue of $3.9 billion, net profit of $383 million, and earnings per share of $0.20. The gross profit was $2.287 billion, and the price-to-earnings ratio stood at 40.58. Among analysts, 38% recommend buying, while 62% suggest holding the stock.
In the personal products sector, which grew by 0.07%, E.L.F. Beauty, European Wax Center, and Yatsen Holding saw notable gains. Kenvue, formerly Johnson & Johnson's consumer division, is a leader in consumer health, offering brands such as Tylenol and Listerine.
